{"id":"https://openalex.org/W2012712901","doi":"https://doi.org/10.1016/j.clpt.2006.05.008","title":"Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs","display_name":"Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2012712901","doi":"https://doi.org/10.1016/j.clpt.2006.05.008","mag":"2012712901","pmid":"https://pubmed.ncbi.nlm.nih.gov/16952487"},"language":"en","primary_location":{"id":"doi:10.1016/j.clpt.2006.05.008","doi":"https://doi.org/10.1016/j.clpt.2006.05.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2006.05.008","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012712901"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Use_of_microdosing_to_predict_pharmacokinetics_at_the_therapeutic_dose_Experience_with_5_drugs/24408622","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108405510","display_name":"Graham Lappin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"G LAPPIN","raw_affiliation_strings":["Xceleron, York Biocentre, Innovation Way, Heslington, York YO10 5NY, United Kingdom","Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xceleron, York Biocentre, Innovation Way, Heslington, York YO10 5NY, United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017294284","display_name":"W. Kuhnz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"W KUHNZ","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R JOCHEMSEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"R JOCHEMSEN","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078735833","display_name":"Johannes Kneer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"J KNEER","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"A CHAUDHARY","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"A CHAUDHARY","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049436470","display_name":"Berend Oosterhuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"B OOSTERHUIS","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108504095","display_name":"W. J. Drijfhout","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"W DRIJFHOUT","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110588033","display_name":"Malcolm Rowland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":false,"raw_author_name":"M ROWLAND","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002760041","display_name":"R. Colin Garner","orcid":"https://orcid.org/0000-0002-7439-7632","observed_orcids":["https://orcid.org/0000-0002-7439-7632"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["CH","GB","US"],"is_corresponding":true,"raw_author_name":"R GARNER","raw_affiliation_strings":["Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","Eli Lilly, Indianapolis","F. Hoffmann-La Roche, Basel","Pharma Bio-Research Group, Zuidlaren","Preclinical Development Pharmacokinetics, Schering, Berlin","R. Colin Garner, DSc, Xceleron, York Biocentre, Innovation Way, Heslington, York YO10 5NY, United Kingdom","Servier Research Group, Courbevoie","Xceleron, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Eli Lilly, Indianapolis","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"F. Hoffmann-La Roche, Basel","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharma Bio-Research Group, Zuidlaren","institution_ids":[]},{"raw_affiliation_string":"Preclinical Development Pharmacokinetics, Schering, Berlin","institution_ids":[]},{"raw_affiliation_string":"R. Colin Garner, DSc, Xceleron, York Biocentre, Innovation Way, Heslington, York YO10 5NY, United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Servier Research Group, Courbevoie","institution_ids":[]},{"raw_affiliation_string":"Xceleron, York","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5002760041"],"corresponding_institution_ids":["https://openalex.org/I118019719","https://openalex.org/I168537998","https://openalex.org/I28407311"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":11.2829,"has_fulltext":false,"cited_by_count":242,"citation_normalized_percentile":{"value":0.99364341,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"80","issue":"3","first_page":"203","last_page":"215"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.08129999786615372,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.017799999564886093,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microdosing","display_name":"microdosing","score":0.968999981880188},{"id":"https://openalex.org/keywords/pharmacokinetic-prediction","display_name":"pharmacokinetic prediction","score":0.843999981880188},{"id":"https://openalex.org/keywords/therapeutic-dose","display_name":"therapeutic dose","score":0.6570000052452087},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8500000238418579},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.9259999990463257},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.996999979019165},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.9129999876022339},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7070000171661377},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.5680000185966492},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.8650000095367432},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.8700000047683716},{"id":"https://openalex.org/keywords/14c-labeled-drug","display_name":"14C-labeled drug","score":0.7210000157356262},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.3700000047683716},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.4180000126361847},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-relationship","display_name":"pharmacokinetic-pharmacodynamic relationship","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C2780913584","wikidata":"https://www.wikidata.org/wiki/Q6839483","display_name":"MicroDose","level":2,"score":0.9054253101348877},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8533897399902344},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.70428466796875},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5467246770858765},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5464774370193481},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5440884828567505},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5110481977462769},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4482543170452118},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.44796374440193176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4166230261325836},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15834486484527588},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.05382540822029114},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.clpt.2006.05.008","doi":"https://doi.org/10.1016/j.clpt.2006.05.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2006.05.008","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:16952487","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16952487","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/24408622","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Use_of_microdosing_to_predict_pharmacokinetics_at_the_therapeutic_dose_Experience_with_5_drugs/24408622","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/24408622","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Use_of_microdosing_to_predict_pharmacokinetics_at_the_therapeutic_dose_Experience_with_5_drugs/24408622","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1487261559","https://openalex.org/W1522171836","https://openalex.org/W1712708601","https://openalex.org/W1895993106","https://openalex.org/W1970578757","https://openalex.org/W1976648897","https://openalex.org/W1986582346","https://openalex.org/W1996394825","https://openalex.org/W2029064284","https://openalex.org/W2030125274","https://openalex.org/W2038929780","https://openalex.org/W2050433577","https://openalex.org/W2054911076","https://openalex.org/W2075737506","https://openalex.org/W2077226523","https://openalex.org/W2088755752","https://openalex.org/W2091711716","https://openalex.org/W2092456450","https://openalex.org/W2101904881","https://openalex.org/W2107567029","https://openalex.org/W2111682379","https://openalex.org/W2121175754","https://openalex.org/W2152798073","https://openalex.org/W2366411924","https://openalex.org/W3013947769"],"related_works":["https://openalex.org/W2163453478","https://openalex.org/W1975460665","https://openalex.org/W1493191390","https://openalex.org/W4234640705","https://openalex.org/W2110971639","https://openalex.org/W2083634919","https://openalex.org/W4246356440","https://openalex.org/W1994996480","https://openalex.org/W2103046315","https://openalex.org/W2095636457"],"abstract_inverted_index":{"OBJECTIVES:":[0],"A":[1],"volunteer":[2],"trial":[3],"was":[4,28,48,114,129,147,164,265,297],"performed":[5],"to":[6,30,52,131,149,312,356],"compare":[7],"the":[8,65,80,281,325,330,340,354],"pharmacokinetics":[9,38,163],"of":[10,37,64,93,109,118,135,170,175,180,183,191,195,200,208,212,216,223,230,234,238,243,301,309,320],"5":[11,66,278,295],"drugs--warfarin,":[12],"ZK253":[13,251],"(Schering),":[14],"diazepam,":[15],"midazolam,":[16,105,137],"and":[17,89,98,106,138,152,160,178,189,198,219,228,241,248,259,274,291],"erythromycin--when":[18],"administered":[19],"at":[20,140],"a":[21,32,57,69,86,299,318],"microdose":[22,70,97,159,308],"or":[23,42,49,342],"pharmacologic":[24],"dose.":[25],"Each":[26],"compound":[27,250],"chosen":[29],"represent":[31],"situation":[33],"in":[34,43,112,284,324,345,358],"which":[35],"prediction":[36],"from":[39,339],"either":[40],"animal":[41],"vitro":[44],"studies":[45],"(or":[46],"both)":[47],"is":[50],"likely":[51],"be":[53],"problematic.":[54],"METHODS:":[55],"In":[56],"crossover":[58],"design":[59],"volunteers":[60],"received":[61],"(1)":[62],"1":[63],"compounds":[67,332],"as":[68,317],"labeled":[71],"with":[72,337],"radioactive":[73],"carbon":[74],"(carbon":[75],"14)":[76],"(100":[77],"microg),":[78],"(2)":[79],"corresponding":[81],"(14)C-labeled":[82,96,110],"therapeutic":[83,101,141,161],"dose":[84,102,162],"on":[85],"separate":[87],"occasion,":[88],"(3)":[90],"simultaneous":[91],"administration":[92],"an":[94,99],"intravenous":[95],"oral":[100,220,307],"for":[103,166,186,203,225,245,255,271,277,288,294,329],"ZK253,":[104,136],"erythromycin.":[107],"Analysis":[108],"drugs":[111],"plasma":[113,133,315],"done":[115],"by":[116,121],"use":[117],"HPLC":[119],"followed":[120],"accelerator":[122],"mass":[123,127,145],"spectrometry.":[124],"Liquid":[125],"chromatography-tandem":[126],"spectrometry":[128,146],"used":[130,148,350],"measure":[132,150],"concentrations":[134],"erythromycin":[139,310],"concentrations,":[142],"whereas":[143],"HPLC-accelerator":[144],"warfarin":[151],"diazepam":[153,167],"concentrations.":[154],"RESULTS:":[155],"Good":[156],"concordance":[157,336],"between":[158],"observed":[165,283],"(half-life":[168],"[t((1/2))]":[169],"45.1":[171],"hours,":[172,193,210,232],"clearance":[173,264],"[CL]":[174],"1.38":[176],"L/h,":[177,197,214,236],"volume":[179],"distribution":[181,285],"[V]":[182],"90.1":[184],"L":[185,202,287,293],"100":[187,226,257,272,289],"microg":[188,227,258,273,290],"t((1/2))":[190,229],"35.7":[192],"CL":[194,211,233],"1.3":[196],"V":[199,215,237],"123":[201],"10":[204],"mg),":[205,247,279],"midazolam":[206],"(t((1/2))":[207],"4.87":[209],"21.2":[213],"145":[217],"L,":[218,240],"bioavailability":[221,328],"[F]":[222],"0.23":[224],"3.31":[231],"20.4":[235],"75":[239],"F":[242],"0.22":[244],"7.5":[246],"development":[249],"(F":[252],"=":[253],"<1%":[254],"both":[256],"50":[260],"mg).":[261],"For":[262],"warfarin,":[263],"reasonably":[266],"well":[267],"predicted":[268],"(0.17":[269],"L/h":[270,276],"0.26":[275],"but":[280],"discrepancy":[282],"(67":[286],"17.9":[292],"mg)":[296],"probably":[298],"result":[300,319],"high-affinity,":[302],"low-capacity":[303],"tissue":[304],"binding.":[305],"The":[306],"failed":[311],"provide":[313],"detectable":[314],"levels":[316],"possible":[321],"acid":[322],"lability":[323],"stomach.":[326],"Absolute":[327],"3":[331],"examined":[333],"yielded":[334],"excellent":[335],"data":[338,343],"literature":[341],"generated":[344],"house.":[346],"CONCLUSION:":[347],"Overall,":[348],"when":[349],"appropriately,":[351],"microdosing":[352],"offers":[353],"potential":[355],"aid":[357],"early":[359],"drug":[360],"candidate":[361],"selection.":[362]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":26}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
